In that setting, particularly among those with underlying heart or kidney disease, the drugs helped improve blood sugar levels, lowered the risk of related complications, aided weight reduction, and reduced the likelihood of early death
Its certainly plausible, in the same way that other medications that help with appetite, such as topiramate, have utility. The problem, said Steinglass, who also serves as director of research at the Eating Disorders Research Clinic, is that large studies of GLP-1 RAs for obesity and diabetes have not included individuals with psychiatric illnesses or EDs, leaving critical gaps in knowledge about their effects in these populations
Proponents, such as the Coverage of GLP-1 medication for weight loss isnt guaranteed
In Kerala, Dr
Though Kochman is pretty vocal about being on Wegovy, the senior said only a few close friends know that she is on Zepbound
Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease
